127 related articles for article (PubMed ID: 11307146)
1. Differential expression of somatostatin receptors in ependymoma: implications for diagnosis.
Guyotat J; Champier J; Jouvet A; Signorelli F; Houzard C; Bret P; Saint Pierre G; Fevre Montange M
Int J Cancer; 2001 May; 95(3):144-51. PubMed ID: 11307146
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.
Mundschenk J; Unger N; Schulz S; Höllt V; Schulz S; Steinke R; Lehnert H
J Clin Endocrinol Metab; 2003 Nov; 88(11):5150-7. PubMed ID: 14602742
[TBL] [Abstract][Full Text] [Related]
3. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in malignant lymphomas: targets for radiotherapy?
Dalm VA; Hofland LJ; Mooy CM; Waaijers MA; van Koetsveld PM; Langerak AW; Staal FT; van der Lely AJ; Lamberts SW; van Hagen MP
J Nucl Med; 2004 Jan; 45(1):8-16. PubMed ID: 14734660
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of somatostatin receptors in medulloblastoma.
Guyotat J; Champier J; Pierre GS; Jouvet A; Bret P; Brisson C; Belin MF; Signorelli F; Montange MF
J Neurooncol; 2001 Jan; 51(2):93-103. PubMed ID: 11386415
[TBL] [Abstract][Full Text] [Related]
7. Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney.
Balster DA; O'Dorisio MS; Summers MA; Turman MA
Am J Physiol Renal Physiol; 2001 Mar; 280(3):F457-65. PubMed ID: 11181407
[TBL] [Abstract][Full Text] [Related]
8. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy.
Papotti M; Croce S; Bellò M; Bongiovanni M; Allìa E; Schindler M; Bussolati G
Virchows Arch; 2001 Dec; 439(6):787-97. PubMed ID: 11787852
[TBL] [Abstract][Full Text] [Related]
9. Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas.
Saveanu A; Muresan M; De Micco C; Taieb D; Germanetti AL; Sebag F; Henry JF; Brunaud L; Enjalbert A; Weryha G; Barlier A
Endocr Relat Cancer; 2011 Apr; 18(2):287-300. PubMed ID: 21335363
[TBL] [Abstract][Full Text] [Related]
10. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
[TBL] [Abstract][Full Text] [Related]
11. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
Asnacios A; Courbon F; Rochaix P; Bauvin E; Cances-Lauwers V; Susini C; Schulz S; Boneu A; Guimbaud R; Buscail L
J Clin Oncol; 2008 Feb; 26(6):963-70. PubMed ID: 18281671
[TBL] [Abstract][Full Text] [Related]
12. Comparison of somatostatin receptor expression in human gliomas and medulloblastomas.
Cervera P; Videau C; Viollet C; Petrucci C; Lacombe J; Winsky-Sommerer R; Csaba Z; Helboe L; Daumas-Duport C; Reubi JC; Epelbaum J
J Neuroendocrinol; 2002 Jun; 14(6):458-71. PubMed ID: 12047721
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor gene expression in neuroblastoma.
Albers AR; O'Dorisio MS; Balster DA; Caprara M; Gosh P; Chen F; Hoeger C; Rivier J; Wenger GD; O'Dorisio TM; Qualman SJ
Regul Pept; 2000 Mar; 88(1-3):61-73. PubMed ID: 10706954
[TBL] [Abstract][Full Text] [Related]
15. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
16. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin and somatostatin subtype 2A expression in the mammalian retina.
Johnson J; Rickman DW; Brecha NC
Microsc Res Tech; 2000 Jul; 50(2):103-11. PubMed ID: 10891874
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of somatostatin receptors in human ovarian tumors.
Schulz S; Schmitt J; Quednow C; Roessner A; Weise W
Gynecol Oncol; 2002 Feb; 84(2):235-40. PubMed ID: 11812080
[TBL] [Abstract][Full Text] [Related]
19. Evidence for Somatostatin receptor 2 in thyroid tissue.
Druckenthaner M; Schwarzer C; Ensinger C; Gabriel M; Prommegger R; Riccabona G; Decristoforo C
Regul Pept; 2007 Jan; 138(1):32-9. PubMed ID: 16996150
[TBL] [Abstract][Full Text] [Related]
20. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
Dabasi G; Hauser P; Kertész GP; Balázs G; Karádi Z; Constantin T; Bognár L; Klekner A; Schuler D; Garami M
Magy Onkol; 2007; 51(3):229-34. PubMed ID: 17922063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
